Genetic Contributions to Prostate Cancer Disparities in Men of West African Descent

Prostate cancer (PCa) is the second most frequently diagnosed malignancy and the second leading cause of death in men worldwide, after adjusting for age. According to the International Agency for Research on Cancer, continents such as North America and Europe report higher incidence of PCa; however,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jabril R. Johnson, Leanne Woods-Burnham, Stanley E. Hooker, Ken Batai, Rick A. Kittles
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/a30a4c20aea04e85a69afc5db9f2fff8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a30a4c20aea04e85a69afc5db9f2fff8
record_format dspace
spelling oai:doaj.org-article:a30a4c20aea04e85a69afc5db9f2fff82021-11-08T07:03:53ZGenetic Contributions to Prostate Cancer Disparities in Men of West African Descent2234-943X10.3389/fonc.2021.770500https://doaj.org/article/a30a4c20aea04e85a69afc5db9f2fff82021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.770500/fullhttps://doaj.org/toc/2234-943XProstate cancer (PCa) is the second most frequently diagnosed malignancy and the second leading cause of death in men worldwide, after adjusting for age. According to the International Agency for Research on Cancer, continents such as North America and Europe report higher incidence of PCa; however, mortality rates are highest among men of African ancestry in the western, southern, and central regions of Africa and the Caribbean. The American Cancer Society reports, African Americans (AAs), in the United States, have a 1.7 increased incidence and 2.4 times higher mortality rate, compared to European American’s (EAs). Hence, early population history in west Africa and the subsequent African Diaspora may play an important role in understanding the global disproportionate burden of PCa shared among Africans and other men of African descent. Nonetheless, disparities involved in diagnosis, treatment, and survival of PCa patients has also been correlated to socioeconomic status, education and access to healthcare. Although recent studies suggest equal PCa treatments yield equal outcomes among patients, data illuminates an unsettling reality of disparities in treatment and care in both, developed and developing countries, especially for men of African descent. Yet, even after adjusting for the effects of the aforementioned factors; racial disparities in mortality rates remain significant. This suggests that molecular and genomic factors may account for much of PCa disparities.Jabril R. JohnsonLeanne Woods-BurnhamStanley E. HookerKen BataiRick A. KittlesFrontiers Media S.A.articlegeneticsprostate cancer geneticsprostate cancer disparitiesGWASVitamin Dprostate cancer screeningNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic genetics
prostate cancer genetics
prostate cancer disparities
GWAS
Vitamin D
prostate cancer screening
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle genetics
prostate cancer genetics
prostate cancer disparities
GWAS
Vitamin D
prostate cancer screening
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Jabril R. Johnson
Leanne Woods-Burnham
Stanley E. Hooker
Ken Batai
Rick A. Kittles
Genetic Contributions to Prostate Cancer Disparities in Men of West African Descent
description Prostate cancer (PCa) is the second most frequently diagnosed malignancy and the second leading cause of death in men worldwide, after adjusting for age. According to the International Agency for Research on Cancer, continents such as North America and Europe report higher incidence of PCa; however, mortality rates are highest among men of African ancestry in the western, southern, and central regions of Africa and the Caribbean. The American Cancer Society reports, African Americans (AAs), in the United States, have a 1.7 increased incidence and 2.4 times higher mortality rate, compared to European American’s (EAs). Hence, early population history in west Africa and the subsequent African Diaspora may play an important role in understanding the global disproportionate burden of PCa shared among Africans and other men of African descent. Nonetheless, disparities involved in diagnosis, treatment, and survival of PCa patients has also been correlated to socioeconomic status, education and access to healthcare. Although recent studies suggest equal PCa treatments yield equal outcomes among patients, data illuminates an unsettling reality of disparities in treatment and care in both, developed and developing countries, especially for men of African descent. Yet, even after adjusting for the effects of the aforementioned factors; racial disparities in mortality rates remain significant. This suggests that molecular and genomic factors may account for much of PCa disparities.
format article
author Jabril R. Johnson
Leanne Woods-Burnham
Stanley E. Hooker
Ken Batai
Rick A. Kittles
author_facet Jabril R. Johnson
Leanne Woods-Burnham
Stanley E. Hooker
Ken Batai
Rick A. Kittles
author_sort Jabril R. Johnson
title Genetic Contributions to Prostate Cancer Disparities in Men of West African Descent
title_short Genetic Contributions to Prostate Cancer Disparities in Men of West African Descent
title_full Genetic Contributions to Prostate Cancer Disparities in Men of West African Descent
title_fullStr Genetic Contributions to Prostate Cancer Disparities in Men of West African Descent
title_full_unstemmed Genetic Contributions to Prostate Cancer Disparities in Men of West African Descent
title_sort genetic contributions to prostate cancer disparities in men of west african descent
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/a30a4c20aea04e85a69afc5db9f2fff8
work_keys_str_mv AT jabrilrjohnson geneticcontributionstoprostatecancerdisparitiesinmenofwestafricandescent
AT leannewoodsburnham geneticcontributionstoprostatecancerdisparitiesinmenofwestafricandescent
AT stanleyehooker geneticcontributionstoprostatecancerdisparitiesinmenofwestafricandescent
AT kenbatai geneticcontributionstoprostatecancerdisparitiesinmenofwestafricandescent
AT rickakittles geneticcontributionstoprostatecancerdisparitiesinmenofwestafricandescent
_version_ 1718442933960572928